Secondary Antifungal Prophylaxis in Pediatric Hematopoietic Stem Cell Transplants
In conclusion, our study shows that amphotericin B and caspofungin was successful as secondary antifungal prophylaxis agents with no relapse of IFI. In addition, after engraftment, secondary prophylaxis was continued with voriconazole orally in 4 patients that yielded good results.
Source: Journal of Pediatric Hematology Oncology - Category: Hematology Tags: Online Articles: Original Articles Source Type: research
More News: Abelcet | Cancer & Oncology | Cancidas | Caspofungin | Children | Fungal Infections | Hematology | Pediatrics | Stem Cell Therapy | Stem Cells | Study | Transplants